Pasithea Therapeutics Cor... (KTTAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -15.51M -13.94M -2.17M -40.98K
Depreciation & Amortization 648.45K 32.37K 1.38K -
Stock-Based Compensation 592.27K 835.06K 471.25K -
Other Working Capital 1.57M -831.78M -329.44K 2.29K
Other Non-Cash Items -121.29K -1.07M 750.00K 9.90K
Deferred Income Tax - - -2.33M -
Change in Working Capital 1.57M -138.44K 111.23K 2.29K
Operating Cash Flow -12.81M -14.56M -3.17M -38.69K
Capital Expenditures -34.3 -2.14M -21.50K -
Acquisitions - 77.06K - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies 433.31K -626.90K - -
Investing Cash Flow 399.01K -2.06M -21.50K -
Debt Repayment - - - -
Common Stock Repurchased -3.73M -3.21M - -
Dividend Paid - - - -
Other Financial Acitivies - -3.21K 5.69M 282.34K
Financial Cash Flow -3.73M -3.21M 55.93M 282.34K
Net Cash Flow -16.76K -19.82M 52.72M 243.65K
Free Cash Flow -13.46M -16.70M -3.20M -38.69K